Literature DB >> 21555743

Crebbp haploinsufficiency in mice alters the bone marrow microenvironment, leading to loss of stem cells and excessive myelopoiesis.

Stephanie N Zimmer1, Qing Zhou, Ting Zhou, Ziming Cheng, Sherry L Abboud-Werner, Diane Horn, Mike Lecocke, Ruth White, Andrei V Krivtsov, Scott A Armstrong, Andrew L Kung, David M Livingston, Vivienne I Rebel.   

Abstract

CREB-binding protein (CREBBP) is important for the cell-autonomous regulation of hematopoiesis, including the stem cell compartment. In the present study, we show that CREBBP plays an equally pivotal role in microenvironment-mediated regulation of hematopoiesis. We found that the BM microenvironment of Crebbp(+/-) mice was unable to properly maintain the immature stem cell and progenitor cell pools. Instead, it stimulates myeloid differentiation, which progresses into a myeloproliferation phenotype. Alterations in the BM microenvironment resulting from haploinsufficiency of Crebbp included a marked decrease in trabecular bone that was predominantly caused by increased osteoclastogenesis. Although CFU-fibroblast (CFU-F) and total osteoblast numbers were decreased, the bone formation rate was similar to that found in wild-type mice. At the molecular level, we found that the known hematopoietic modulators matrix metallopeptidase-9 (MMP9) and kit ligand (KITL) were decreased with heterozygous levels of Crebbp. Lastly, potentially important regulatory proteins, endothelial cell adhesion molecule 1 (ESAM1) and cadherin 5 (CDH5), were increased on Crebbp(+/-) endothelial cells. Our findings reveal that a full dose of Crebbp is essential in the BM microenvironment to maintain proper hematopoiesis and to prevent excessive myeloproliferation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21555743      PMCID: PMC3139388          DOI: 10.1182/blood-2010-09-307942

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  49 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Cloning of an immunoglobulin family adhesion molecule selectively expressed by endothelial cells.

Authors:  T Ishida; K Penta; M Rezaee; E Yang; J Wohlgemuth; T Quertermous
Journal:  J Biol Chem       Date:  2001-02-13       Impact factor: 5.157

Review 3.  Rubinstein-Taybi syndrome: clinical and molecular overview.

Authors:  Jeroen H Roelfsema; Dorien J M Peters
Journal:  Expert Rev Mol Med       Date:  2007-08-20       Impact factor: 5.600

4.  Assessment of Gelatinases (MMP-2 and MMP-9 by Gelatin Zymography.

Authors:  M Toth; R Fridman
Journal:  Methods Mol Med       Date:  2001

5.  Two transactivation mechanisms cooperate for the bulk of HIF-1-responsive gene expression.

Authors:  Lawryn H Kasper; Fayçal Boussouar; Kelli Boyd; Wu Xu; Michelle Biesen; Jerold Rehg; Troy A Baudino; John L Cleveland; Paul K Brindle
Journal:  EMBO J       Date:  2005-10-20       Impact factor: 11.598

6.  Transcriptional activation of cartilage oligomeric matrix protein by Sox9, Sox5, and Sox6 transcription factors and CBP/p300 coactivators.

Authors:  Chuan-ju Liu; Yan Zhang; Ke Xu; Deidre Parsons; Daniel Alfonso; Paul E Di Cesare
Journal:  Front Biosci       Date:  2007-05-01

7.  Cleavage of cartilage oligomeric matrix protein (thrombospondin-5) by matrix metalloproteinases and a disintegrin and metalloproteinase with thrombospondin motifs.

Authors:  Sally C Dickinson; Mireille N Vankemmelbeke; David J Buttle; Krisztina Rosenberg; Dick Heinegård; Anthony P Hollander
Journal:  Matrix Biol       Date:  2003-05       Impact factor: 11.583

8.  Chromatin acetylation, memory, and LTP are impaired in CBP+/- mice: a model for the cognitive deficit in Rubinstein-Taybi syndrome and its amelioration.

Authors:  Juan M Alarcón; Gaël Malleret; Khalid Touzani; Svetlana Vronskaya; Shunsuke Ishii; Eric R Kandel; Angel Barco
Journal:  Neuron       Date:  2004-06-24       Impact factor: 17.173

9.  The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein.

Authors:  J Borrow; V P Stanton; J M Andresen; R Becher; F G Behm; R S Chaganti; C I Civin; C Disteche; I Dubé; A M Frischauf; D Horsman; F Mitelman; S Volinia; A E Watmore; D E Housman
Journal:  Nat Genet       Date:  1996-09       Impact factor: 38.330

10.  Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand.

Authors:  Beate Heissig; Koichi Hattori; Sergio Dias; Matthias Friedrich; Barbara Ferris; Neil R Hackett; Ronald G Crystal; Peter Besmer; David Lyden; Malcolm A S Moore; Zena Werb; Shahin Rafii
Journal:  Cell       Date:  2002-05-31       Impact factor: 41.582

View more
  19 in total

1.  Osteoclasts and hematopoiesis.

Authors:  Anna Teti
Journal:  Bonekey Rep       Date:  2012-03-28

2.  Inhibition of WNT signaling in the bone marrow niche prevents the development of MDS in the Apcdel/+ MDS mouse model.

Authors:  Angela Stoddart; Jianghong Wang; Chunmei Hu; Anthony A Fernald; Elizabeth M Davis; Jason X Cheng; Michelle M Le Beau
Journal:  Blood       Date:  2017-03-27       Impact factor: 22.113

Review 3.  Myelodysplastic syndromes: revisiting the role of the bone marrow microenvironment in disease pathogenesis.

Authors:  Marc H G P Raaijmakers
Journal:  Int J Hematol       Date:  2012-01-06       Impact factor: 2.490

Review 4.  Revisiting the case for genetically engineered mouse models in human myelodysplastic syndrome research.

Authors:  Ting Zhou; Marsha C Kinney; Linda M Scott; Sandra S Zinkel; Vivienne I Rebel
Journal:  Blood       Date:  2015-06-15       Impact factor: 22.113

Review 5.  Pathogenic Mechanisms in Acute Myeloid Leukemia.

Authors:  Sohini Chakraborty; Christopher Y Park
Journal:  Curr Treat Options Oncol       Date:  2022-10-03

Review 6.  Modeling human hematopoietic stem cell biology in the mouse.

Authors:  Stephen M Sykes; David T Scadden
Journal:  Semin Hematol       Date:  2013-06-11       Impact factor: 3.851

Review 7.  Bone marrow niches in haematological malignancies.

Authors:  Simón Méndez-Ferrer; Dominique Bonnet; David P Steensma; Robert P Hasserjian; Irene M Ghobrial; John G Gribben; Michael Andreeff; Daniela S Krause
Journal:  Nat Rev Cancer       Date:  2020-02-28       Impact factor: 60.716

8.  The transcriptional coactivator Cbp regulates self-renewal and differentiation in adult hematopoietic stem cells.

Authors:  Wai-In Chan; Rebecca L Hannah; Mark A Dawson; Clare Pridans; Donna Foster; Anagha Joshi; Berthold Göttgens; Jan M Van Deursen; Brian J P Huntly
Journal:  Mol Cell Biol       Date:  2011-10-17       Impact factor: 4.272

9.  Somatic mutation of CDKN1B in small intestine neuroendocrine tumors.

Authors:  Joshua M Francis; Adam Kiezun; Alex H Ramos; Stefano Serra; Chandra Sekhar Pedamallu; Zhi Rong Qian; Michaela S Banck; Rahul Kanwar; Amit A Kulkarni; Anna Karpathakis; Veronica Manzo; Tanupriya Contractor; Juliet Philips; Elizabeth Nickerson; Nam Pho; Susanne M Hooshmand; Lauren K Brais; Michael S Lawrence; Trevor Pugh; Aaron McKenna; Andrey Sivachenko; Kristian Cibulskis; Scott L Carter; Akinyemi I Ojesina; Samuel Freeman; Robert T Jones; Douglas Voet; Gordon Saksena; Daniel Auclair; Robert Onofrio; Erica Shefler; Carrie Sougnez; Jonna Grimsby; Lisa Green; Niall Lennon; Tim Meyer; Martyn Caplin; Daniel C Chung; Andreas S Beutler; Shuji Ogino; Christina Thirlwell; Ramesh Shivdasani; Sylvia L Asa; Chris R Harris; Gad Getz; Matthew Kulke; Matthew Meyerson
Journal:  Nat Genet       Date:  2013-11-03       Impact factor: 38.330

10.  CREBBP knockdown suppressed proliferation and promoted chemo-sensitivity via PERK-mediated unfolded protein response in ovarian cancer.

Authors:  Haoyang Hu; Sheng Yin; Ruyue Ma; Rujun Chen; Shuqing Li; Yaping Chen; He Fei; Lina Yang
Journal:  J Cancer       Date:  2021-06-01       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.